Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

SOD1 and breast cancer are reported together in 3 articles.

Gene

SOD1

HGNC
HGNC:11179
60articles
60mentions
3variants with confirmed gene link
Most co-reported phenotypes (articles)
Reported variants (articles · ClinVar status)
Phenotype

Breast cancer

1,211articles
1,211mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

3 records shown · first 60
TypeEntitySource evidenceConfidenceExtractor
geneSOD1“Assessing the Association Between Genetic Variants in ACE, SOD1, and PER3 and their Role in Breast Cancer Risk among Jordanian Women.”0.98hgnc_dict_v1
phenotypebreast cancer“Assessing the Association Between Genetic Variants in ACE, SOD1, and PER3 and their Role in Breast Cancer Risk among Jordanian Women.”0.98phenotype_alias_lexicon_v2
geneACE“Assessing the Association Between Genetic Variants in ACE, SOD1, and PER3 and their Role in Breast Cancer Risk among Jordanian Women.”0.98hgnc_dict_v1
genePER3“Assessing the Association Between Genetic Variants in ACE, SOD1, and PER3 and their Role in Breast Cancer Risk among Jordanian Women.”0.98hgnc_dict_v1

Synthesis and multilevel evaluation of benzimidazole-based anticancer compounds: DNA/serum albumin interaction, and in-depth theoretical insights.

PMID 42334525 | PMCID PMC13524987 | DOI 10.1007/s11010-026-05600-3 · Molecular and cellular biochemistry · 2026 · 6 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneSOD1“Also, to elucidate the anticancer mechanism of compounds, pro-apoptotic BAX and BiD, anti-apoptotic BCL2 and BCL-xl, oxidant enzymes PRDX1 and SOD1 levels were examined by RT-qPCR.”0.98hgnc_dict_v1
phenotypebreast cancer“Compounds 3a and 3b were tested utilizing the MTT study to evaluate their in vitro cytotoxic activity against healthy human embryonic kidney, lung cancer, breast cancer, and human liver cancer cell lines.”0.98phenotype_alias_lexicon_v2
geneBCL2“Also, to elucidate the anticancer mechanism of compounds, pro-apoptotic BAX and BiD, anti-apoptotic BCL2 and BCL-xl, oxidant enzymes PRDX1 and SOD1 levels were examined by RT-qPCR.”0.98hgnc_dict_v1
genePRDX1“Also, to elucidate the anticancer mechanism of compounds, pro-apoptotic BAX and BiD, anti-apoptotic BCL2 and BCL-xl, oxidant enzymes PRDX1 and SOD1 levels were examined by RT-qPCR.”0.98hgnc_dict_v1

Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells.

PMID 37298090 | PMCID PMC10252622 | DOI 10.3390/ijms24119141 · International journal of molecular sciences · 2023 · 3 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneSOD1“The qPCR quantification showed the upregulation of caspase 3, caspase 9, bax, and SOD1 genes in GRO-NLs-treated cells.”0.98hgnc_dict_v1
phenotypebreast cancer“Effectiveness of Nonfunctionalized Graphene Oxide Nanolayers as Nanomedicine against Colon, Cervical, and Breast Cancer Cells.”0.98phenotype_alias_lexicon_v2
geneCDC25C“Western blotting showed the depletion of P21, P53, and CDC25C proteins in the above cancer cell lines after GRO-NLs treatment, indicating its function as a mutagen to induce mutation in the P53 gene, thereby affecting P53 protein and downstream effectors P21 and CDC25C.”0.98hgnc_dict_v1